Supporting material "Acquired Willebrand syndrome during continuous or pulsatile extracorporeal carbon dioxide removal"

Description

Two consecutive prospective monocentric observational ECCO2R studies (NCT 02965079 and 05079009) were conducted involving the Hemolung (Hemolung Group 1, n=8) and iLA Activve (iLA-continuous Group 2, n=12) devices under continuous extracorporeal blood flow and the iLA Activve device set to the “Advanced” mode (iLA-pulsatile Group 3, n=6), allowing a pulsatile extracorporeal flow. Since some baseline imbalances were observed, adjusted analyses were performed and are presented as supporting material in Mendeley Data

Institutions

• Université Paris Cité

  Île-de-France, Paris

Categories

Licence